Optimal platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention.
Fiore, Mathieu
Optimal platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention. [electronic resource] - Resuscitation Sep 2018 - e1-e2 p. digital
Publication Type: Letter
1873-1570
10.1016/j.resuscitation.2018.06.032 doi
Adenosine Monophosphate--administration & dosage
Biological Availability
Coma--etiology
Female
Humans
Male
Middle Aged
Out-of-Hospital Cardiac Arrest--complications
Percutaneous Coronary Intervention--methods
Platelet Function Tests--methods
Purinergic P2Y Receptor Antagonists--administration & dosage
Ticagrelor--administration & dosage
Treatment Outcome
Optimal platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention. [electronic resource] - Resuscitation Sep 2018 - e1-e2 p. digital
Publication Type: Letter
1873-1570
10.1016/j.resuscitation.2018.06.032 doi
Adenosine Monophosphate--administration & dosage
Biological Availability
Coma--etiology
Female
Humans
Male
Middle Aged
Out-of-Hospital Cardiac Arrest--complications
Percutaneous Coronary Intervention--methods
Platelet Function Tests--methods
Purinergic P2Y Receptor Antagonists--administration & dosage
Ticagrelor--administration & dosage
Treatment Outcome